HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.

AbstractBACKGROUND:
Alcohol is a common cause of hepatic liver injury with steatosis and fibrosis. Cannabinoid receptors (CB) modulate steatosis, inflammation and fibrogenesis. To investigate the differences between CB(1) and CB(2) in the hepatic response to chronic alcohol intake, we examined CB knockout mice (CB(1)(-/-), CB(2)(-/-)).
METHODS:
Eight- to 10-week-old CB(1)(-/-), CB(2)(-/-) and wild-type mice received 16% ethanol for 35 weeks. Animals receiving water served as controls. We analysed triglyceride and hydroxyproline contents in liver homogenates. mRNA levels of CBs, pro-inflammatory cytokines [tumour necrosis factor (TNF)-α, monocyte chemotactic protein (MCP)-1, interleukin (IL)-1β] and profibrotic factors [α-smooth muscle actin (α-SMA), procollagen-Ia, platelet-derived growth factor β receptor (PDGFβ-R)] were analysed by reverse transcription-polymerase chain reaction (RT-PCR). Histology (hemalaun and eosin, oil-red O, CD3, CD45R, CD45, F4/80, Sirius red) characterized hepatic steatosis, inflammation and fibrosis. Activation of lipogenic pathways, activation and proliferation of hepatic stellate cell (HSC) were assessed by western blot [fatty acid synthase (FAS), sterol regulatory element binding protein 1c (SREBP-1c), α-SMA, proliferating cell nuclear antigen (PCNA), cathepsin D].
RESULTS:
Hepatic mRNA levels of the respective CBs were increased in wild-type animals and in CB(1)(-/-) mice after ethanol intake. Ethanol intake in CB(2)(-/-) mice induced much higher steatosis (SREBP-1c mediated) and inflammation (B-cell predominant infiltrates) compared with wild-type animals and CB(1)(-/-) mice. HSC activation and collagen production were increased in all groups after forced ethanol intake, being most pronounced in CB(2)(-/-) mice and least pronounced in CB(1)(-/-) mice.
DISCUSSION:
The fact that CB(2) receptor knockout mice exhibited the most pronounced liver damage after ethanol challenge indicates a protective role of CB(2) receptor expression in chronic ethanol intake. By contrast, in CB(1) knockouts, the effect of ethanol was attenuated, suggesting aggravation of fibrogenesis and SREBP-1c-mediated steatosis via CB(1) receptor expression after ethanol intake.
AuthorsJonel Trebicka, Ildiko Racz, Sören V Siegmund, Erlind Cara, Michaela Granzow, Robert Schierwagen, Sabine Klein, Alexandra Wojtalla, Martin Hennenberg, Sebastian Huss, Hans-Peter Fischer, Jörg Heller, Andreas Zimmer, Tilman Sauerbruch
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 31 Issue 6 Pg. 860-70 (Jul 2011) ISSN: 1478-3231 [Electronic] United States
PMID21645218 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 John Wiley & Sons A/S.
Chemical References
  • Biomarkers
  • Inflammation Mediators
  • RNA, Messenger
  • Receptor, Cannabinoid, CB1
  • Receptor, Cannabinoid, CB2
  • Triglycerides
  • Ethanol
  • Hydroxyproline
Topics
  • Animals
  • Biomarkers (metabolism)
  • Blotting, Western
  • Cell Proliferation
  • Disease Models, Animal
  • Ethanol (blood)
  • Fatty Liver, Alcoholic (genetics, immunology, metabolism, pathology)
  • Female
  • Gene Expression Regulation
  • Hepatic Stellate Cells (metabolism, pathology)
  • Hepatitis, Alcoholic (genetics, immunology, metabolism, pathology)
  • Hydroxyproline (metabolism)
  • Inflammation Mediators (metabolism)
  • Liver (immunology, metabolism, pathology)
  • Liver Cirrhosis, Alcoholic (genetics, immunology, metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • RNA, Messenger (metabolism)
  • Receptor, Cannabinoid, CB1 (deficiency, genetics)
  • Receptor, Cannabinoid, CB2 (deficiency, genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: